(Q44473362)

English

Development and evaluation of a flow-cytometric assay of specific cell-mediated immune response in activated whole blood for the detection of cell-mediated immunity against varicella-zoster virus

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

Development and evaluation of a flow-cytometric assay of specific cell-mediated immune response in activated whole blood for the detection of cell-mediated immunity against varicella-zoster virus (English)

1 reference

Europe PubMed Central

3 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Svahn A

1

1 reference

Europe PubMed Central

3 December 2017

Linde A

2

1 reference

Europe PubMed Central

3 December 2017

Thorstensson R

3

1 reference

Europe PubMed Central

3 December 2017

Karlén K

4

1 reference

Europe PubMed Central

3 December 2017

Andersson L

5

1 reference

Europe PubMed Central

3 December 2017

Gaines H

6

1 reference

Europe PubMed Central

3 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 June 2003

1 reference

Europe PubMed Central

3 December 2017

Journal of Immunological Methods

1 reference

Europe PubMed Central

3 December 2017

277

1 reference

Europe PubMed Central

3 December 2017

1-2

1 reference

Europe PubMed Central

3 December 2017

17-25

1 reference

Europe PubMed Central

3 December 2017

Varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900111-X

7 January 2021

Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900111-X

7 January 2021

Whole-blood lymphocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900111-X

7 January 2021

Recent advances in varicella-zoster virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900111-X

7 January 2021

The incidence of herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900111-X

7 January 2021

A simplified microtechnique for measuring human lymphocyte proliferation after stimulation with mitogen and specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900111-X

7 January 2021

A new method for measuring lymphoproliferation at the single-cell level in whole blood cultures by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900111-X

7 January 2021

Determination of varicella immunity by the indirect immunofluorescence test in urgent clinical situations

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900111-X

7 January 2021

Cell-mediated immunity to varicella-zoster virus: in vitro lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900111-X

7 January 2021

A whole-blood lymphoproliferation assay for measuring cellular immunity against herpes viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900111-X

7 January 2021

Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900111-X

7 January 2021

Lymphocyte proliferation and IgG production with herpesvirus antigens in solid phase

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900111-X

7 January 2021

Lymphocyte activation. VIII. The application of a whole blood test to the qauntitative analysis of PHA responsive T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900111-X

7 January 2021

Immunization to reduce the frequency and severity of herpes zoster and its complications

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900111-X

7 January 2021

In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900111-X

7 January 2021

Frequency and specificity of varicella zoster virus IgM response

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900111-X

7 January 2021

An interchangeable elisa for cytomegalovirus antigen and antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900111-X

7 January 2021

Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900111-X

7 January 2021

Lymphoproliferative responses to human herpesvirus-6 variant A and variant B in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900111-X

7 January 2021

Development of a whole blood assay to measure T cell responses to leprosy: a new tool for immuno-epidemiological field studies of leprosy immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900111-X

7 January 2021

Identifiers

10.1016/S0022-1759(03)00111-X

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44473362&oldid=2025200907"